Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) Director Jennifer Straumins sold 37,861 shares of the stock in a transaction that occurred on Wednesday, December 18th. The stock was sold at an average price of $21.42, for a total transaction of $810,982.62. Following the sale, the director now owns 1,184,589 shares in the company, valued at approximately $25,373,896.38. This trade represents a 3.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Jennifer Straumins also recently made the following trade(s):
- On Tuesday, November 12th, Jennifer Straumins sold 100,000 shares of Calumet Specialty Products Partners stock. The stock was sold at an average price of $20.59, for a total value of $2,059,000.00.
Calumet Specialty Products Partners Price Performance
NASDAQ CLMT opened at $20.39 on Friday. The company has a fifty day moving average of $21.32 and a two-hundred day moving average of $18.09. The company has a market capitalization of $1.75 billion, a PE ratio of -7.39 and a beta of 1.91. Calumet Specialty Products Partners, L.P. has a 1 year low of $9.97 and a 1 year high of $25.29.
3 CENT Crypto to Explode December 16th?
From True Market Insiders | Ad
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017…
And has spotted 44 different coins that have returned over 100%...
But today, Chris is now making the biggest crypto call of his ENTIRE career…
#1 FREE Crypto for 2025
Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last announced its earnings results on Friday, November 8th. The oil and gas company reported ($1.18) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.59) by ($0.59). The firm had revenue of $1.10 billion for the quarter, compared to analyst estimates of $888.36 million. During the same quarter in the previous year, the business posted $0.03 EPS. The company's revenue was down 4.3% on a year-over-year basis. On average, research analysts expect that Calumet Specialty Products Partners, L.P. will post -2.87 earnings per share for the current year.
Institutional Trading of Calumet Specialty Products Partners
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Raymond James & Associates raised its stake in shares of Calumet Specialty Products Partners by 13.4% during the second quarter. Raymond James & Associates now owns 572,057 shares of the oil and gas company's stock worth $9,182,000 after purchasing an additional 67,689 shares during the last quarter. Wasserstein Debt Opportunities Management L.P. grew its holdings in Calumet Specialty Products Partners by 2.9% during the second quarter. Wasserstein Debt Opportunities Management L.P. now owns 6,891,314 shares of the oil and gas company's stock worth $110,606,000 after acquiring an additional 193,063 shares during the period. Creative Planning raised its position in Calumet Specialty Products Partners by 46.4% in the second quarter. Creative Planning now owns 62,459 shares of the oil and gas company's stock worth $1,002,000 after acquiring an additional 19,800 shares in the last quarter. Founders Financial Alliance LLC boosted its position in shares of Calumet Specialty Products Partners by 8.4% during the 2nd quarter. Founders Financial Alliance LLC now owns 48,400 shares of the oil and gas company's stock worth $777,000 after purchasing an additional 3,750 shares in the last quarter. Finally, DRW Securities LLC purchased a new position in shares of Calumet Specialty Products Partners in the 2nd quarter valued at about $898,000. 34.41% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on the company. StockNews.com upgraded Calumet Specialty Products Partners to a "sell" rating in a report on Monday, November 18th. Wells Fargo & Company upped their target price on shares of Calumet Specialty Products Partners from $25.00 to $29.00 and gave the stock an "overweight" rating in a research note on Monday, October 21st. HC Wainwright reiterated a "buy" rating and issued a $25.00 price target on shares of Calumet Specialty Products Partners in a research note on Monday, November 11th. Finally, TD Cowen dropped their price objective on shares of Calumet Specialty Products Partners from $27.00 to $26.00 and set a "buy" rating on the stock in a research report on Monday, November 11th. One research analyst has rated the stock with a sell rating and four have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $23.75.
Check Out Our Latest Analysis on Calumet Specialty Products Partners
About Calumet Specialty Products Partners
(
Get Free Report)
Calumet, Inc manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally. It operates through Specialty Products and Solutions; Montana/Renewables; and Performance brands segments.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
